Gilead Will Begin Marketing Lower Cost Hepatitis C Drugs in January

Gilead Sciences Inc. announced that it would begin selling generic versions of the company’s two leading treatments for hepatitis C at substantially reduced prices.  The generic versions of Epclusa and…